Cargando…
VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
Blockading programmed death ligand 1 (PD-L1) shows promising results in patients with some cancers, but not in those with ovarian cancer. V-domain Ig suppressor of T cell activation (VISTA) is a recently discovered immune checkpoint protein that suppresses T cell activation. This study aimed to inve...
Autores principales: | Zong, Liju, Zhou, Yuncan, Zhang, Ming, Chen, Jie, Xiang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949319/ https://www.ncbi.nlm.nih.gov/pubmed/31781843 http://dx.doi.org/10.1007/s00262-019-02434-5 |
Ejemplares similares
-
VISTA is associated with immune infiltration and predicts favorable prognosis in TNBC
por: Zhang, Mi, et al.
Publicado: (2022) -
VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer
por: Jlassi, Aida, et al.
Publicado: (2023) -
Markers of T Cell Infiltration and Function Associate with Favorable Outcome in Vascularized High-Grade Serous Ovarian Carcinoma
por: Townsend, Katelin N., et al.
Publicado: (2013) -
VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
por: Cao, Xi, et al.
Publicado: (2021) -
Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness
por: Wang, Zhihang, et al.
Publicado: (2022)